Record ID | marc_records_scriblio_net/part20.dat:166428324:1582 |
Source | Scriblio |
Download Link | /show-records/marc_records_scriblio_net/part20.dat:166428324:1582?format=raw |
LEADER: 01582cam 2200373 a 4500
001 89070679
003 DLC
005 20030910184749.0
008 891201s1990 gw a b 000 0 eng
010 $a 89070679
020 $a3527273786 (Weinheim)
020 $a0895739631 (New York)
040 $aDLC$cDLC$dDLC
050 00 $aRB56.5.A43$bA45 1990
082 00 $a615/.7$220
245 00 $aAmiodarone profile /$cedited by Robert A.A. Maes ; and compiled by David W. Holt, Theo A. Plomp, and William J. McKenna.
260 $aWeinheim ;$aNew York :$bVCH,$cc1990.
300 $aviii, 44 p. :$bill. ;$c21 cm.
490 1 $aReport 13 of the Senate Commission for Clinical-Toxicological Analysis,$x0930-7958 =$aMitteilung 13 der Senatskommission für Klinisch-toxikologische Analytik
500 $aAt head of title: DFG Deutsche Forschungsgemeinschaft.
504 $aIncludes bibliographical references.
650 0 $aAmiodarone$xAnalysis.
650 0 $aAmiodarone$xPharmacokinetics.
650 0 $aBlood$xAnalysis.
650 0 $aHigh performance liquid chromatography.
650 0 $aPatient monitoring.
700 1 $aMaes, R. A. A.$q(Robert A. A.),$d1937-
700 1 $aHolt, David W.
700 1 $aPlomp, Theo A.
700 1 $aMcKenna, William J.,$cM.D.
710 2 $aDeutsche Forschungsgemeinschaft.
830 0 $aReport ... of the Senate Commission for Clinical-Toxicological Analysis ;$v13.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/description/wiley031/89070679.html
856 4 $3Table of Contents$uhttp://www.loc.gov/catdir/toc/onix01/89070679.html